EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Human monoclonal antibodies targeting A35 protect from death caused by mpox

Raianna F Fantin, Meng Yuan, Seok-Chan Park, Bailey Bozarth, Hallie Cohn, Maxinne Ignacio, Patricia Earl, Alesandro Civljak, Gabriel Laghlali, Ding Zhang, Xueyong Zhu, Jameson Crandell und 22 weitere

Cell · 2025-10 · 188 (22) · 6236-6252.e18

DOI: 10.1016/j.cell.2025.08.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2025-10. Verfasst von Raianna F Fantin und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center for Vaccine Research and Pandemic Preparedness, Icahn …. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Antibodies, Viral, Mpox, Monkeypox, Monkeypox virus. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 2022 mpox outbreak highlighted the serious threat of monkeypox virus (MPXV), yet effective treatments are lacking. From an mpox-convalescent individual, we identified three high-affinity human monoclonal antibodies (mAbs) (named EV35-2, EV35-6, and EV35-7) that target the A35 protein in MPXV. These antibodies block viral spread in vitro and protect mice against lethal MPXV and vaccinia virus infection via both Fc-dependent and independent mechanisms. Levels of serum antibodies targeting the same epitopes are increased in mpox-convalescent humans, and higher levels of these antibodies in the sera are linked to shorter symptom duration and no hospitalization. Systems-level multivariate analysis indicated that mpox-convalescent serum antibodies targeting the same epitopic region as these three mAbs may function cooperatively, with additive associations to clinical protection. Two of the antibodies use a conserved IGHD2-21-encoded CxGGDCx motif in their CDRH3 region to bind a highly conserved poxvirus epitope. These findings establish A35 as a critical therapeutic target and highlight A35-specific mAbs as promising candidates for next-generation orthopoxvirus treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalAntibodies, ViralMpox, MonkeypoxMonkeypox virusViral ProteinsHumansAnimalsMiceFemaleEpitopesMaleVaccinia virusMice, Inbred BALB C

Stichwörter der Autor:innen

A35MPXVVACVcrystal structureepitopememory B cellsmonoclonal antibodiesmpoxorthopoxvirustherapy

Substanzen

Antibodies, MonoclonalAntibodies, ViralEpitopesViral Proteins

Autor:innen und Institutionen

  • Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center for Vaccine Research and Pandemic Preparedness, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; The Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; The Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pharm…

Förderung

  • NIGMS NIH HHS
  • NIAID NIH HHS
  • NCI NIH HHS
  • National Institutes of Health
  • Icahn School of Medicine at Mount Sinai
  • Stavros Niarchos Foundation
  • Brookhaven National Laboratory
  • Basic Energy Sciences

Zitieren

APA

Fantin, R. F., Yuan, M., Park, S. C., Bozarth, B., Cohn, H., Ignacio, M., Earl, P., Civljak, A., Laghlali, G., Zhang, D., Zhu, X., Crandell, J., Monteiro, V., Clark, J. J., Cotter, C., Burkhardt, M., Singh, G., Warang, P., García-Bernalt Diego, J., …, & Coelho, C. H. (2025). Human monoclonal antibodies targeting A35 protect from death caused by mpox. Cell, 188(22), 6236-6252.e18. https://doi.org/10.1016/j.cell.2025.08.004

Vancouver

Fantin RF, Yuan M, Park SC, Bozarth B, Cohn H, Ignacio M, et al. Human monoclonal antibodies targeting A35 protect from death caused by mpox. Cell. 2025;188(22):6236-6252.e18. doi:10.1016/j.cell.2025.08.004

BibTeX
@article{Fantin2025,
  author = {Fantin, Raianna F and Yuan, Meng and Park, Seok-Chan and Bozarth, Bailey and Cohn, Hallie and Ignacio, Maxinne and Earl, Patricia and Civljak, Alesandro and Laghlali, Gabriel and Zhang, Ding and Zhu, Xueyong and Crandell, Jameson and Monteiro, Valter and Clark, Jordan J and Cotter, Catherine and Burkhardt, Martin and Singh, Gagandeep and Warang, Prajakta and García-Bernalt Diego, Juan and Srivastava, Komal and Lugo, Luz A and Pischel, Lauren and PVI study group, PVI study group and Yildirim, Inci and Omer, Saad B and da Silva, Daniel and Krammer, Florian and Bajic, Goran and Simon, Viviana and Schotsaert, Michael and Lucas, Carolina and Wilson, Ian A and Moss, Bernard and Coelho, Camila H},
  title = {Human monoclonal antibodies targeting A35 protect from death caused by mpox},
  journal = {Cell},
  year = {2025},
  volume = {188},
  number = {22},
  pages = {6236--6252.e18},
  doi = {10.1016/j.cell.2025.08.004}
}
Kostenlos starten →